Bio-Techne Announces Strategic Investment in Eminence
MINNEAPOLIS, Jan. 28, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced an initial minority strategic equity investment in Changzhou Eminence Biotechnology Co., Ltd. (“Eminence”). Eminence will use the financing proceeds to expand its manufacturing capacity and increase the... Read more